Christophe Lonchay

501 total citations
12 papers, 387 citations indexed

About

Christophe Lonchay is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Christophe Lonchay has authored 12 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Christophe Lonchay's work include Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers) and Lung Cancer Research Studies (4 papers). Christophe Lonchay is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers) and Lung Cancer Research Studies (4 papers). Christophe Lonchay collaborates with scholars based in Belgium, Luxembourg and France. Christophe Lonchay's co-authors include Lionel D’Hondt, Thierry Boon, Didier Colau, Jean-Luc Canon, Pierre G. Coulie, Sophie Lucas, Takeshi Hanagiri, Thierry Connerotte, Aline Van Pel and Nicolas van Baren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Immunological Reviews.

In The Last Decade

Christophe Lonchay

12 papers receiving 373 citations

Peers

Christophe Lonchay

IMMUN

ONCOL

PRM

OTORH

David Livingstone Alves Figueiredo Brazil

Harumi Saeki Japan

Xing Su China

Pooi Pooi Leong Malaysia

Fai Ng Hong Kong

Hui Jia United Kingdom

Oscar Orozco Colombia

Dolores Schendel Germany

Bert Kindlund Sweden

Krystle A. Lang Kuhs United States

David Livingstone Alves Figueiredo Brazil

Christophe Lonchay

120 ×0.5

IMMUN

83 ×0.5

ONCOL

189 ×1.3

32 ×0.4

PRM

73 ×1.7

OTORH

Citations per year, relative to Christophe Lonchay Christophe Lonchay (= 1×) peers David Livingstone Alves Figueiredo

Countries citing papers authored by Christophe Lonchay

Since Specialization

Citations

This map shows the geographic impact of Christophe Lonchay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Lonchay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Lonchay more than expected).

Fields of papers citing papers by Christophe Lonchay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Lonchay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Lonchay. The network helps show where Christophe Lonchay may publish in the future.

Co-authorship network of co-authors of Christophe Lonchay

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Lonchay. A scholar is included among the top collaborators of Christophe Lonchay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Lonchay. Christophe Lonchay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Seront, Emmanuel, Sandra Schmitz, Aline van Maanen, et al.. (2019). Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck. Frontiers in Oncology. 9. 155–155. 17 indexed citations

Seront, Emmanuel, Sandra Schmitz, Sylvie Rottey, et al.. (2016). Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Annals of Oncology. 27. vi345–vi345. 3 indexed citations

Rottey, Sylvie, Aline van Maanen, Jean‐Marie Vandenbulcke, et al.. (2015). Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) previously treated with platinum-based therapy.. Journal of Clinical Oncology. 33(15_suppl). 6051–6051. 1 indexed citations

André, Marc, et al.. (2010). Clostridium tertium bacteremia: contamination or true pathogen? A report of two cases and a review of the literature. International Journal of Infectious Diseases. 14. e335–e337. 24 indexed citations

Giralt, J., José Trigo, Sandra Nuyts, et al.. (2009). 8516 A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis. European Journal of Cancer Supplements. 7(2). 475–475. 1 indexed citations

Detrait, Marie Y., Lionel D’Hondt, M. André, et al.. (2008). Agrobacterium radiobacter bacteremia in oncologic and geriatric patients: presentation of two cases and review of the literature. International Journal of Infectious Diseases. 12(6). e7–e10. 15 indexed citations

D’Hondt, Lionel, et al.. (2007). Ovarian cancer associated with carcinomatous meningitis: a case report and review of the literature. International Journal of Gynecological Cancer. 17(5). 1136–1140. 3 indexed citations

D’Hondt, Lionel, et al.. (2006). Oral mucositis induced by anticancer treatments: physiopathology and treatments. Therapeutics and Clinical Risk Management. 2(2). 159–168. 68 indexed citations

Joncker, Nathalie T., Christophe Lonchay, Simone Cuff, et al.. (2005). Antigen‐independent accumulation of activated effector/memory T lymphocytes into human and murine tumors. International Journal of Cancer. 118(5). 1205–1214. 20 indexed citations

10.

Lonchay, Christophe, Pierre van der Bruggen, Thierry Connerotte, et al.. (2004). Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proceedings of the National Academy of Sciences. 101(suppl_2). 14631–14638. 121 indexed citations

11.

Kobayashi, Tatsuya, Christophe Lonchay, Didier Colau, et al.. (2003). New MAGE‐4 antigenic peptide recognized by cytolytic T lymphocytes on HLA‐A1 tumor cells. Tissue Antigens. 62(5). 426–432. 13 indexed citations

12.

Coulie, Pierre G., Vaios Karanikas, Christophe Lurquin, et al.. (2002). Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigen. Immunological Reviews. 188(1). 33–42. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact